These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10737671)

  • 1. Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion.
    Bischoff A; Michel MC
    Can J Physiol Pharmacol; 2000 Feb; 78(2):93-9. PubMed ID: 10737671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis.
    Bischoff A; Rascher W; Michel MC
    Am J Physiol; 1998 Oct; 275(4):F502-9. PubMed ID: 9755121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats.
    Bischoff A; Limmroth V; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):704-8. PubMed ID: 9694924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Nifedipine on Renal and Cardiovascular Responses to Neuropeptide Y in Anesthetized Rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of neuropeptide Y.
    Bischoff A; Michel MC
    Pflugers Arch; 1998 Mar; 435(4):443-53. PubMed ID: 9446690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
    Bischoff A; Erdbrügger W; Smits J; Michel MC
    J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):525-34. PubMed ID: 8887762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
    Wang SJ
    Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasotocin analogues with selective natriuretic, kaliuretic and antidiuretic effects in rats.
    Kutina AV; Marina AS; Shakhmatova EI; Natochin YV
    Regul Pept; 2013 Aug; 185():57-64. PubMed ID: 23835093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoclopramide stimulates kaliuresis during felodipine without affecting its natriuresis.
    van Hamersvelt HW; Wetzels JF; Koene RA; Huysmans FT
    Hypertension; 1994 Nov; 24(5):633-9. PubMed ID: 7960025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.
    Heredia Mdel P; Delgado C; Pereira L; Perrier R; Richard S; Vassort G; Bénitah JP; Gómez AM
    J Mol Cell Cardiol; 2005 Jan; 38(1):205-12. PubMed ID: 15623437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.
    Gao J; Ghibaudi L; Hwa JJ
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E706-11. PubMed ID: 15187000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in the natriuresis induced by central administration of angiotensin II.
    Israel A; Arzola J; De Jesús S; Varela M
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):9-14. PubMed ID: 19286753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of brain cholinergic system in renal sodium, potassium and water excretion in rats].
    Jiang CL; Lin MZ
    Sheng Li Xue Bao; 1994 Aug; 46(4):361-8. PubMed ID: 7973827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
    Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
    Adewale AS; Macarthur H; Westfall TC
    Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.